SCHEMBL31663610

SCHEMBL31663610

Cc1ccc2c(c1)c1ccccc1n2-c1ccc(-c2cc(-c3ccccc3)c(-c3ccccc3)cc2C#N)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
KDM4E B2RXH2 5/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ATM Q13315 1/20 0.39
ALDH1A1 P00352 6/20 0.37
HPGD P15428 4/20 0.37
GAA P10253 2/20 0.37
MAPK1 P28482 2/20 0.37
GALR3 O60755 1/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PDE9A O76083 1/20 0.35
PDE1C Q14123 1/20 0.35
GLA P06280 1/20 0.35
CASP1 P29466 1/20 0.35
RECQL P46063 1/20 0.35
CASP7 P55210 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24548199 0.94 KDM4E (0.38) CYP1A2CYP2C9CYP2C19NPSR1KDM4E
SCHEMBL31273735 0.91 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19NPSR1KDM4E
SCHEMBL31663520 0.88 PDE9A (0.38) CYP1A2CYP2C9CYP2C19NPSR1KDM4E
SCHEMBL24548198 0.87 USP14 (0.40) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL17955129 0.86 GRM2 (0.38) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL31663554 0.85 PDE9A (0.40) CYP1A2CYP2C9CYP2C19NPSR1KDM4E
SCHEMBL31663564 0.85 PDE9A (0.38) CYP1A2CYP2C9CYP2C19NPSR1KDM4E
SCHEMBL31663632 0.85 PDE9A (0.40) CYP1A2CYP2C9CYP2C19NPSR1KDM4E
SCHEMBL17955124 0.85 GRM2 (0.41) CYP1A2CYP2C9CYP2C19NPSR1KDM4E
SCHEMBL17483295 0.85 KDM4E (0.43) CYP1A2CYP2C9CYP2C19NPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 CYP1A2 540/4885CYP2C9 925/4885CYP2C19 795/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 CYP1A2 540/4885CYP2C9 925/4885CYP2C19 795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.